BRNS
Barinthus Biotherapeutics
BRNS
BRNS
19 hedge funds and large institutions have $10.7M invested in Barinthus Biotherapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.58% less ownership
Funds ownership: 25.4% → 24.82% (-0.58%)
9% less capital invested
Capital invested by funds: $11.8M → $10.7M (-$1.02M)
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$14.4K | |
| 2 | +$12.5K | |
| 3 | +$7.72K | |
| 4 |
Morgan Stanley
New York
|
+$3.7K |
| 5 |
Renaissance Technologies
New York
|
+$3.33K |
Top Sellers
| 1 | -$209K | |
| 2 | -$101K | |
| 3 | -$6K | |
| 4 |
IIM
Ipswich Investment Management
Beverly,
Massachusetts
|
-$595 |